Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma

NCT03168061 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Soft Tissue Sarcoma
Metastatic Sarcoma
Sarcoma

Interventions

DRUG: NC 6300

Sponsor

NanoCarrier Co., Ltd.